Biomarker Strategies Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Biomarker Strategies

Access the complete profile.

Biomarker Strategies Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	621511 Medical Laboratories
Address	15601 Crabbs Branch Way Rockville, MD 20855

Note: Revenues for privately held companies are statistical evaluations.


Biomarker Strategies's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Biomarker Strategies's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Biomarker Strategies is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Biomarker Strategies Annual Revenue and Growth Rate

Biomarker Strategies	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Biomarker Strategies's revenues are gauged from an analysis of company filings.

Biomarker Strategies's Income Statement (based on Industry Averages)

Biomarker Strategies P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Biomarker Strategies is developing and marketing. Biomarker Strategies doesn't have any recent trademark applications, indicating Biomarker Strategies is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
PATHMAP Medical diagnostic assays for determining susceptibility of a subject's cancer to particular treatment regimens	10/26/2012
SNAPPATH Clinical laboratory instruments for analysis of biological fluids, cells and tissues; laboratory plates, glass slides, tubes and chips for use in multi-well arrays for use in analysis of blood and other fluids	02/28/2011
BIOMARKER STRATEGIES Performing scientific research or providing scientific research services to identify the most informative, effective and efficient panels of biomarkers to aid in the new drug development and clinical trial process; Providing biomarker-related technical consulting, scientific research, assay development, and testing services to support new drug development and clinical trials; Conducting scientific research related to the discovery and identification of novel biomarkers of interest; Providing scientific research services to pharmaceutical companies, Contract Research Organizations (CROs), and diagnostic testing companies to support the integration of molecular biomarker assays into clinical trials and new drug/product codevelopment efforts; Developing biomarker molecular assays, including multiplexed assays, to assist with pre-clinical drug development and pharmacokinetic and pharmacodynamic scientific studies; and to assist with clinical trials to evaluate clinical trial safety, efficacy, toxicology, and dosing; Providing technical consulting and scientific research services to identify and use a full range of germline and tissue-specific DNA, RNA and protein- based molecular biomarkers, including-- single nucleotide polymorphisms (SNPs), DNA point mutations, deletions, translocations, inversions and amplifications, DNA methylation, microbial DNA detection, gene expression analysis (mRNA), protein expression and modification (phosphorylation, acetylation, methylation), lipid analysis, carbohydrate analysis, and whole cell analysis	05/02/2006

See all trademarks and details in the Full Report.

Market Share of Biomarker Strategies's Largest Competitors

A competitive analysis shows these companies are in the same general field as Biomarker Strategies, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Biomarker Strategies. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
OTSUKA AMERICA PHARMACEUTICAL	Rockville, MD	100
HENRY M. JACKSON FOUNDATION FOR ADVANCEMENT OF MILITARY MEDICINE	Bethesda, MD	85
MESO SCALE DIAGNOSTICS	Rockville, MD	36
ROBOTIC RESEARCH OPCO	Clarksburg, MD	29
MACROGENICS	Rockville, MD	11
EVIDERA	Bethesda, MD	10

Other Companies at 15601 Crabbs Branch Way, Rockville MD

Company	Headquarters	Revenue ($ MM)
CAMBRIDGE MEDICAL TECHNOLOGIES	Rockville, MD	100
BRIGENE BIOSCIENCES	Rockville, MD	37
INTERSPACE	Derwood, MD	0
STB	Rockville, MD	0
CLINITECH	Rockville, MD	0

Future Competition: Biomarker Strategies's Fastest Growing Competitors

These companies are in the same general field as Biomarker Strategies and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)